A new protein antagonist design strategy shows promise against leukaemia by targeting important receptors to stop the proliferation of cancer cells. A new family of protein-based antagonists has been ...
This study addresses fundamental questions surrounding otitis media effusion in Down syndrome, identifying DYRK1A as a key gene involved in the condition. The findings are compelling, highlighting ...